neurology-2018-keynote

Page 26

Notes:

allied

academies

August 23-24, 2018 | Paris, France

Neurology and Neurological Disorders

International Conference on

Journal of Neurology and Neurorehabilitation Research | Volume 3

Clinic which operated parallel to physician stroke prevention

clinic will involve. Comprehensive medication profile reviews and

patient interview will be performed. The interventions will be

discussed with the physician. Patients with approved interventions

related to antidiabetic agents or antihypertensive medication will

be followed by telephone call one week later and four weeks after

appointment.

Inclusion and exclusion criteria

Inclusion criteria:

All patients with appointment in the stroke prevention clinic

who received approved clinical pharmacist intervention

All patients with appointment in the stroke prevention clinic with

poor medication adherence.

Exclusion criteria:

Patients with appointment in the stroke prevention clinic who are

not on any medication.

Outcome Measures:

Primary outcome: Measure the effects of

clinical pharmacist interventions by reaching the target fasting

and postprandial blood glucose level and target blood pressure

according to the case.

Secondary outcomes:

Feedback of clinical pharmacist

intervention on patients reported adverse drug events.

To measure improvement of patient’s medication adherence by

decreasing the number of missing doses per week.

Speaker Biography

Nahed Lubbad is currently working as a Clinical Pharmacist at King Fahad Medical City,

Saudi Arabia. His experiences include Medication Therapy Management (MTM) Clinic,

Stroke Prevention Clinical Pharmacist, Medication Utilisation Committee Coordinator,

Clinical Pharmacist, Drug and Poison Information Clinical Pharmacist and Medication

reconciliation Clinical Pharmacist at King Fahad Medical City from the year 2011 till present.